Norton (Waterford) Ltd t/a Teva Pharmaceuticals Ireland v Boehringer Ingelheim Pharma Gmbh & Company Kg (No.1) and Others

Core Citations

CONSIDERS

• Ranbaxy Laboratories Ltd v Warner Lambert Company
• The Minister for Justice Equality and Law Reform v Stafford
• SKM SA v Wagner Spraytech (U.K.) Ltd

REFERS TO

• Medinol Ltd (plaintiff) v Abbott Ireland & Others

CONSIDERS

• Medtronic Inc. and Others v Guidant Corporation and Others
• Hannon v Commissioner of Public Works and Others
• Framus Ltd v CRH Plc

APPLIES

• Astrazeneca AB and Others v Pinewood Laboratories Ltd
• Re Astrazeneca AB

FOLLOWS

• Ranbaxy Laboratories Ltd v Warner Lambert Company

REPORTED OPINION OF in

• [2015] 3 JIC 2719
• 2015 WJSC-HC 21181

This document cites

• Framus Ltd v CRH Plc
• The Minister for Justice Equality and Law Reform v Stafford
• Ranbaxy Laboratories Ltd v Warner Lambert Company
• Astrazeneca AB and Others v Pinewood Laboratories Ltd
• Medinol Ltd (plaintiff) v Abbott Ireland & Others



See all quotations

• Ranbaxy Laboratories Ltd v Warner Lambert Company
• Hannon v Commissioner of Public Works and Others
• Re Astrazeneca AB
• Medtronic Inc. and Others v Guidant Corporation and Others
• SKM SA v Wagner Spraytech (U.K.) Ltd
• Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products
• Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance)
• Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance)